Pilot study of treatment of biochemotherapy-refractory stage IV melanoma patients with autologous dendritic cells pulsed with a heterologous melanoma cell line lysate

Author： Vilella R.   Benítez D.   Milà J.   Lozano M.   Vilana R.   Pomes J.   Tomas X.   Costa J.   Vilalta A.   Malvehy J.   Puig S.   Mellado B.   Martí R.   Castel T.  

Publisher： Springer Publishing Company

ISSN： 0340-7004

Source： Cancer Immunology, Immunotherapy, Vol.53, Iss.7, 2004-07, pp. : 651-658

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate

By Salcedo Margarita   Bercovici Nadège   Taylor Rachel   Vereecken Pierre   Massicard Séverine   Duriau Dominique   Vernel-Pauillac Frédérique   Boyer Aurélie   Baron-Bodo Véronique   Mallard Eric   Bartholeyns Jacques   Goxe Béatrice   Latour Nathalie   Leroy Sophie   Prigent Didier   Martiat Philippe   Sales François   Laporte Marianne   Bruyns Catherine   Romet-Lemonne Jean-Loup   Abastado Jean-Pierre   Lehmann Frédéric   Velu Thierry  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 7, 2006-07 ,pp. : 819-829

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates

By Griffioen Marieke   Borghi Martina   Schrier Peter   Osanto Susanne   Schadendorf Dirk  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 8, 2004-08 ,pp. : 715-722

Springer Publishing Company

Access to resources Recommend Favorite

Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34+ progenitor-derived dendritic cells

By Fay Joseph   Palucka A.   Paczesny Sophie   Dhodapkar Madhav   Johnston Dennis   Burkeholder Susan   Ueno Hideki   Banchereau Jacques  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 10, 2006-10 ,pp. : 1209-1218

Springer Publishing Company

Access to resources Recommend Favorite

Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study

By Ardon Hilko   Gool Stefaan   Lopes Isabel   Maes Wim   Sciot Raf   Wilms Guido   Demaerel Philippe   Bijttebier Patricia   Claes Laurence   Goffin Jan   Calenbergh Frank   Vleeschouwer Steven  

Journal of Neuro-Oncology, Vol. 99, Iss. 2, 2010-09 ,pp. : 261-272

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma

By Hersey P.   Halliday G.   Farrelly M.   DeSilva C.   Lett M.   Menzies S.  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 7, 2008-07 ,pp. : 1039-1051

Springer Publishing Company

Access to resources Recommend Favorite